Unlike IRA contributions, 401(k) contributions generally must be paid during the calendar year to be deductible from that year's income.
Roivant Sciences and Pfizer Inc. said Thursday that they created a new company focused on developing and commercializing an ulcerative colitis treatment currently in a Phase 2b clinical study. Roivant's stock was up 7.1% in premarket trading on Thursday, while shares of Pfizer were down 0.5%. The new company, of which Pfizer owns 25%, can also fund development of the drug, RVT-3101, as a treatment for other inflammatory and fibrotic diseases. Pfizer has commercialization rights outside of the U.
Workday reported earnings that fell from a year earlier but topped estimates. The company slightly raised its full-year subscription outlook.
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
CrowdStrike reported third-quarter profit and revenue that topped estimates but its revenue outlook missed Wall Street targets.
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Dividend stocks. They’re the very picture of the reliable standby, the sound defensive play that investors make when markets turn south. Div stocks tend not to show as extreme shifts as the broader markets, and they offer a steady income stream no matter where the markets go. And it’s not just retail investors who move into dividend stocks. Recent regulatory filings show that billionaire Steve Cohen has bought big into high-yield dividend stocks, the classic defensive move for investors aiming t
Yahoo Finance Live checks out shares of the Blackstone Group after announcing limits to withdrawals from real estate funds.
With shares of Axsome Therapeutics (NASDAQ: AXSM) skyrocketing 87% so far this year, the biotech's shareholders are doubtlessly pleased. Thanks to a pair of newly approved products, growth is finally on the way -- with revenue set to go from practically $0 to more than $100 million in the course of a year.
Yahoo Finance’s Jared Blikre breaks down how stocks are trading following the November jobs report.
In this article, we talk about 10 long-term stock picks in billionaire Ray Dalio’s portfolio. If you want to see more stocks in this selection, check out Billionaire Ray Dalio’s 5 Long-Term Stock Picks. Raymond Thomas Dalio is an American billionaire investor and hedge fund manager, who has served as co-chief investment officer of Bridgewater […]
Anavex Life Sciences said its experimental Alzheimer's treatment met the goals of a midstage study, leading AVXL stock to rocket early Friday.
The stock market got a bit of unexpected news early Friday that sent stock index futures sharply lower before the start of trading on Friday morning. The latest government employment report showed stronger job growth than many economists had expected, and that threw cold water on the idea that the Federal Reserve might quickly slow its pace of interest rate hikes. In particular, stocks of cloud companies UiPath (NYSE: PATH) and Samsara (NYSE: IOT) were up significantly after they released their latest financial reports.
In this article, we discuss the 11 best aggressive stocks to buy now. If you want to read about some more aggressive stocks, go directly to the 5 Best Aggressive Stocks to Buy Now. Aggressive stocks are high-risk, high-reward growth stocks that can provide investors with strong returns. Growth stocks offer a substantially higher growth […]
Today we will run through one way of estimating the intrinsic value of Microsoft Corporation ( NASDAQ:MSFT ) by...
2022 has been a disaster for Palantir Technologies' (NYSE: PLTR) stock -- it's down 61% this year. Despite solid revenue growth, Palantir is still unprofitable, which is a red flag for many investors in times of macroeconomic uncertainty. With 2023 around the corner, could it be the year investors take notice of Palantir's stock?
A rising tide may lift all ships, but famous investor Warren Buffett once said, "Only when the tide goes out do you discover who's been swimming naked." The global pandemic event definitely saw the tide go out, and fortunes for both the world's largest cruise company, Carnival Corporation (NYSE: CCL), and fast-growing pet-supply company Chewy, Inc. (NYSE: CHWY) changed dramatically. Now, with a global return to normalcy underway, these two seem ready to tackle the challenges ahead and come out as winners in the consumer spending space.
No one can say whether that will happen next year, but even if it doesn't, there are plenty of companies that can deliver excellent returns despite heightened market volatility and a struggling economy. Let's consider two examples: Eli Lilly (NYSE: LLY) and Visa (NYSE: V). Pharma giant Eli Lilly has been flying high all year despite its financial results not being particularly impressive.
You may not be familiar with the organization, but there's a good chance you're using a product containing semiconductor chips made by Taiwan Semiconductor Manufacturing (NYSE: TSM). TSMC (as it's better known) manufactures chips for chip design companies that aren't willing or able to make their own. If you've been paying close attention of late, you've likely noticed the global semiconductor shortage is motivating chip brands to take more of their manufacturing destinies into their own hands.
(Bloomberg) -- Stock investors’ optimism around a cooling labor market and a Federal Reserve pivot is overdone, according to Bank of America Corp. strategists, who recommend selling the rally ahead of a likely surge in job losses next year.Most Read from BloombergMusk’s Neuralink Hopes to Implant Computer in Human Brain in Six MonthsGoldman Jolts Traders With Bonus Warning After Bumper HaulBeverly Hills Cop Was California’s Highest-Paid Municipal WorkerMusk Suspends Ye From Twitter After Offensi